levoleucovorin and Parkinson-Disease

levoleucovorin has been researched along with Parkinson-Disease* in 1 studies

Trials

1 trial(s) available for levoleucovorin and Parkinson-Disease

ArticleYear
Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trial.
    Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:1

    Folinic acid (15 mg bid, po) was administered in a two week, double-blind, placebocontrolled, cross over clinical trial in 5 patients with Parkinson's disease (Hoehn and Yahr stage I or II). 4 patients had not been on L-dopa treatment prior to entering this trial and one patient was on a small dose of L-dopa. No significant improvement could be detected in this pilot study by clinical evaluation and motor performance assessed by a computer assisted motor performance test.

    Topics: Adult; Aged; Double-Blind Method; Female; Humans; Leucovorin; Male; Middle Aged; Parkinson Disease; Psychomotor Performance

1992